Develop More Clinically Successful Bispecifics
Attend World Bispecific to realize the next generation of bispecific drugs. Over 3 days, 27 leading experts will share transferable insights to accelerate the development of your lead bispecific candidate, and see more in the clinic. Focusing solely on bispecific development, this technical forum offers you an unrivalled wealth of scientific content. And with this, delivers you the tools for developing more clinically robust bispecific drugs. Last year saw the ground-breaking approval of Blinatunomab for ALL. Reaching this landmark, and with an additional 30+ bispecifics currently in clinical development, we are on the cusp of these drugs coming of age. But, realizing their full potential is not without challenge, so now is the time to attend World Bispecific. Learn key lessons from your peers. Improve your clinical success.